Go back

Coronavirus developments at a glance: 30 January to 5 February

The latest coverage of the Covid-19 pandemic from Research Professional News


University heads from institutions on both sides of the Atlantic have stressed the need to rebuild their academic communities in the wake of damage from the Covid-19 pandemic.

Most nations lack proper systems to keep track of deaths, the World Health Organization has warned, underscoring the need for better data on health amid the ongoing Covid-19 pandemic.

Australia and New Zealand

Early career researchers in New Zealand are experiencing “reduced opportunities” and need extra support, the Ministry of Business, Innovation and Employment has said.


The German Rectors’ Conference, an association of university leaders, has warned that the impact of the Covid-19 pandemic could stifle the careers of young researchers and stall the entire science system.

The European Commission has granted an EU approval for the Covid-19 vaccine developed by the British-Swedish company AstraZeneca, amid the escalation of a row over the slow pace of vaccine deliveries in the bloc and the measures the Commission has taken in response.

The Swedish government and higher education authorities must provide clearer policies to alleviate the impact of the coronavirus pandemic on postdoctoral students, according to the Swedish Network of Postdoc Associations.


A US-based company, ImmunityBio, has acquired worldwide rights to technology developed in the UK to deliver Covid-19 vaccines in a pill or tablet form, and has now started clinical trials.

Science and engineering professionals have suffered some of the lowest Covid-19 death rates, according to the latest data from the Office for National Statistics.